Want to see TSE:PCLO full AI Analyst Report?
PharmaCielo (PCLO) Ratios
PharmaCielo Ratios
TSE:PCLO's free cash flow for Q2 2026 was $-227.86K. For the 2026 fiscal year, TSE:PCLO's free cash flow was increased by $0.00 and operating cash flow was $-227.86K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Jun 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.15 | 0.11 | 0.16 | 0.58 | 1.14 |
| Quick Ratio | 0.08 | 0.04 | 0.05 | 0.27 | 0.86 |
| Cash Ratio | 0.01 | 0.01 | 0.00 | 0.02 | 0.66 |
| Solvency Ratio | -0.15 | -0.30 | -0.62 | -0.77 | -1.54 |
| Operating Cash Flow Ratio | -0.04 | -0.09 | -0.24 | -1.40 | -2.49 |
| Short-Term Operating Cash Flow Coverage | -0.05 | -0.12 | -0.33 | -17.60 | -253.03 |
| Net Current Asset Value | $ -20.26M | $ -23.47M | $ -20.64M | $ -14.71M | $ -7.43M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 2.18 | 1.12 | 0.82 | 0.50 | 0.23 |
| Debt-to-Equity Ratio | -1.21 | -2.73 | -10.90 | 1.97 | 0.44 |
| Debt-to-Capital Ratio | 5.66 | 1.58 | 1.10 | 0.66 | 0.30 |
| Long-Term Debt-to-Capital Ratio | 0.00 | -1.65 | 2.92 | 0.65 | 0.27 |
| Financial Leverage Ratio | -0.56 | -2.45 | -13.27 | 3.93 | 1.86 |
| Debt Service Coverage Ratio | -0.05 | -0.24 | -0.66 | -5.60 | -39.22 |
| Interest Coverage Ratio | -1.38 | -1.42 | -3.39 | -7.19 | -45.37 |
| Debt to Market Cap | 2.20 | 1.46 | 0.63 | 0.46 | 0.05 |
| Interest Debt Per Share | 0.11 | 0.14 | 0.13 | 0.09 | 0.06 |
| Net Debt to EBITDA | -18.31 | -4.43 | -1.50 | -1.18 | -0.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 28.97% | 21.00% | -88.78% | 15.58% | -221.51% |
| EBIT Margin | -76.61% | -168.63% | -882.34% | -227.57% | -1316.01% |
| EBITDA Margin | -38.40% | -132.27% | -790.59% | -197.82% | -1277.10% |
| Operating Profit Margin | -146.43% | -140.87% | -629.22% | -215.87% | -1309.24% |
| Pretax Profit Margin | -174.39% | -262.70% | -1057.09% | -273.45% | -1369.14% |
| Net Profit Margin | -174.39% | -262.70% | -1057.09% | -302.11% | -1383.94% |
| Continuous Operations Profit Margin | -174.39% | -262.70% | -1057.09% | -273.45% | -1369.14% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 110.48% | 101.08% |
| EBT Per EBIT | 119.09% | 186.48% | 168.00% | 126.68% | 104.57% |
| Return on Assets (ROA) | -53.17% | -49.70% | -73.12% | -63.85% | -74.86% |
| Return on Equity (ROE) | 29.65% | 121.62% | 970.31% | -250.90% | -139.28% |
| Return on Capital Employed (ROCE) | 24.90% | 172.64% | -1110.22% | -63.09% | -91.32% |
| Return on Invested Capital (ROIC) | -116.13% | -37.68% | -58.34% | -60.38% | -90.58% |
| Return on Tangible Assets | -53.17% | -49.70% | -73.12% | -63.85% | -74.86% |
| Earnings Yield | -53.83% | -65.20% | -56.56% | -60.70% | -18.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.22 | 5.82 | 2.03 | 3.78 | 3.44 |
| Payables Turnover | 0.35 | 0.48 | 0.52 | 0.73 | 0.81 |
| Inventory Turnover | 1.08 | 1.83 | 1.26 | 2.10 | 2.74 |
| Fixed Asset Turnover | 0.53 | 0.22 | 0.08 | 0.26 | 0.07 |
| Asset Turnover | 0.30 | 0.19 | 0.07 | 0.21 | 0.05 |
| Working Capital Turnover Ratio | -0.13 | -0.19 | -0.15 | -5.87 | 2.45 |
| Cash Conversion Cycle | -607.47 | -498.65 | -236.57 | -227.36 | -212.15 |
| Days of Sales Outstanding | 86.57 | 62.72 | 180.18 | 96.65 | 106.06 |
| Days of Inventory Outstanding | 338.28 | 199.82 | 289.83 | 173.67 | 133.13 |
| Days of Payables Outstanding | 1032.32 | 761.20 | 706.58 | 497.69 | 451.34 |
| Operating Cycle | 424.85 | 262.55 | 470.01 | 270.33 | 239.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.06 | -0.14 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.07 | -0.15 |
| Dividend Paid and CapEx Coverage Ratio | -84934.42 | -492345.00 | -337.29 | -18.60 | -17.64 |
| Capital Expenditure Coverage Ratio | -84934.42 | -492345.00 | -337.29 | -18.60 | -17.64 |
| Operating Cash Flow Coverage Ratio | -0.05 | -0.10 | -0.28 | -0.77 | -2.38 |
| Operating Cash Flow to Sales Ratio | -0.39 | -0.57 | -3.34 | -1.83 | -10.32 |
| Free Cash Flow Yield | -12.05% | -14.05% | -17.93% | -38.72% | -14.86% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.79 | -8.00 | -1.77 | -1.65 | -5.30 |
| Price-to-Sales (P/S) Ratio | 3.24 | 4.03 | 18.69 | 4.98 | 73.38 |
| Price-to-Book (P/B) Ratio | -0.55 | -1.87 | -17.16 | 4.13 | 7.39 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.30 | -7.12 | -5.58 | -2.58 | -6.73 |
| Price-to-Operating Cash Flow Ratio | -8.30 | -7.12 | -5.60 | -2.72 | -7.11 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.09 | 0.19 | 0.04 | 0.10 |
| Enterprise Value Multiple | -26.75 | -7.47 | -3.86 | -3.70 | -5.87 |
| Enterprise Value | 26.82M | 34.40M | 47.06M | 38.84M | 145.82M |
| EV to EBITDA | -26.75 | -7.47 | -3.86 | -3.70 | -5.87 |
| EV to Sales | 10.27 | 9.88 | 30.52 | 7.32 | 74.97 |
| EV to Free Cash Flow | -26.31 | -17.47 | -9.11 | -3.80 | -6.87 |
| EV to Operating Cash Flow | -26.31 | -17.47 | -9.14 | -4.00 | -7.26 |
| Tangible Book Value Per Share | -0.08 | -0.04 | -0.01 | 0.04 | 0.13 |
| Shareholders’ Equity Per Share | -0.08 | -0.04 | -0.01 | 0.04 | 0.13 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.10 | -0.01 |
| Revenue Per Share | 0.01 | 0.02 | 0.01 | 0.04 | 0.01 |
| Net Income Per Share | -0.02 | -0.05 | -0.10 | -0.11 | -0.18 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.10 | 1.01 |
| Interest Burden | 2.28 | 1.56 | 1.20 | 1.20 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1.75 | 1.56 | 5.12 | 2.02 | 9.22 |
| Stock-Based Compensation to Revenue | 0.01 | 0.30 | 1.00 | 0.42 | 3.51 |
| Income Quality | 0.22 | 0.22 | 0.32 | 0.67 | 0.75 |
Currency in CAD
